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                      INTRODUCTION 
           “Diabetes Mellitus is a complex metabolic disorder   which results 
from absolute or relative deficiency in insulin secretion and or its 
action”[51]. There has been a continuous increase in the global 
prevalence of diabetes and its devastating effects on life expectancy and 
quality of life of individuals. 
            Diabetes is a major health issue in most of the South East Asian 
countries, especially in India where carbohydrates form the bulk of staple 
food. Sedentary life style and decrease in day to day physical activities 
along with high calorie junk foods which is popular among the youth is 
another important factor in the increase in trend of diabetes world wide. 
Every second individual in the world will be affected by diabetics soon. 
 Diabetes is appropriately described as a “ Metabolic-Cum-Vascular” 
disorder. There are several types of diabetes which includes Type 1 D.M, 
and Type 2 D.M, other types includes Gestational diabetes in pregnant 
mothers (GDM), Latent autoimmune diabetes of  adults(LADA),Maturity 
Onset Diabetes of Young (MODY) and so on. 
           India has the largest diabetic population in the world and is 
infamously dubbed as “The Diabetic capital” of the world. According to 
Indian council of Medical Research (ICMR), India is faced with 
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galloping diabetes epidemic, approximately more than 70 million  
patients are affected with diabetes in India and this number is projected to 
cross  beyond hundred million by the year 2030 
        Diabetic neuropathy is a common complication of diabetes, 
specifically diabetic autonomic neuropathy, which can affect many 
systems. Though autonomic dysfunction is common in diabetes, 
symptomatic autonomic disturbances are less common. Cardiac 
dysautonomia is associated  with  resting tachycardia, orthostatic 
hypotension, painless myocardial ischemia or infarction, cardiac 
arrhythmias and even sudden cardiac death. 
          Among all diabetes, Type 2 Diabetes Mellitus  accounts for more 
than 80 percent of  diagnosed cases of diabetes cardiac autonomic 
neuropathy. Cardiovascular autonomic neuropathy (CAN) is one of the 
serious complications among diabetics. CAN contributes to poor 
prognosis of coronary artery disease in diabetes  . 
          Early recognition of asymptomatic cardiac dysautonomia helps in 
delaying or arresting its progression. The autonomic function tests are 
mostly non invasive and do not require sophisticated equipments 
Therefore, it has very important clinical and prognostic relevance.  
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Diabetic patients having regional  sympathetic  imbalance  and QTc  
interval   prolongation  are  greater    risk   for   arrhythmias[5].   Early  in  
1980s[5],various studies revealed  an association of prolonged QTc 
interval and cardiovascular autonomic neuropathy. These led to finding  
the possibility of using simple  rapid objective tests for earlier  detection 
of patients having cardiac autonomic neuropathy. 
This  study  was  performed  to  estimate  the  prevalence  of  CAN  
among diabetics in our hospital using simple bedside tests and to study 
the usefulness of corrected qt interval in diagnosing it. 
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AIMS AND OBJECTIVES 
1.   To study the prevalence of Cardiac Autonomic Neuropathy among 
Type 2 Diabetes Mellitus patients in Government Kilpauk Medical 
College Hospital,Chennai. 
2.  To study the use of QTc prolongation in the  prediction of cardiac 
autonomic neuropathy in Type 2 diabetes mellitus (DM) patients in 
Government Kilpauk Medical College Hospital. 
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REVIEW OF LITERATURE 
Type 2 diabetes is one of the major distressing non-communicable 
diseases worldwide ,which shows an increasing prevalence especially in 
developing countries like India. Diabetes is a “Metabolic cum Vascular 
disorder” causing long term damage and dysfunction, which leads to 
failure of various organs like kidneys, eyes, heart  and blood vessels. 
 Even after decades of insulin discovery, diabetic patients still have 
a considerably reduced life expectancy despite a significant decrease in 
incidence of acute metabolic events like ketoacidosis. This is mainly due 
to long term macrovascular and microvascular complications. Among 
non-communicable diseases, growth of diabetes appears to dramatic and  
worrisome. 
“One of the most neglected and underdiagnosed among  
complications related to diabetes mellitus is cardiovascular autonomic 
neuropathy.  It is  a chronic complication of diabetes which involves 
damage to sympathetic and parasympathetic fibres  of  heart which results 
in alteration in control of heart rate and blood pressure”[52]. The clinical 
symptoms include high heart rate in resting state, fall in BP during 
standing, decreased tolerance to exercise, altered sweating response , loss 
of heart rate variation during deep breathing, painless and symptomless 
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heart attack and even sudden cardiac death..Thus, autonomic dysfunction  
not only affects daily activities of diabetic individuals  , but it may even 
cause potentially life threatening outcomes. 
CHRONIC COMPLICATIONS OF DIABETES 
1. Microvacular  
A. Eye disease 
· Retinopathy (non proliferative/proliferative) 
· Macular disease 
B. Neuropathy 
· Sensory and motor neuropathy 
· Autonomic neuropathy 
C. Nephropathy  
2. Macrovascular 
A. Coronary heart didease 
B. Peripheral arterial disease 
C. Cerebrovascular disease 
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Other complications are gastrointestinal, genitourinary, dermatological, 
cheiroarthropathy, periodontal disease etc. 
DIABETIC NEUROPATHY 
Diabetic  Neuropathy  is heterogenous in its clinical presentation. It is the 
commonest complication of diabetes and is associated with significant 
morbidity. When there are signs and symptoms of peripheral nerve 
involvement in diabetes patients, a diagnosis of diabetic neuropathy is 
made after excluding  other causes. This condition poses a therapeutic 
challenge to the treating physician . It has multifactorial pathogenic 
mechanism and varied clinical presentations. Hence treating these 
patients and curing them is difficult and the effectiveness of therapy 
given is mostly not satisfying to the patient. Syndrome of diabetic 
neuropathy and its panaroma of clinical manisfestations has been studied 
in greater detail with respect to pathogenesis and ultrastructural changes 
in peripheral nerves. Hyperglycemia contributes  a major role in its 
pathogenesis. 
 Risk factors for diabetic neuropathy 
1. Poor glucose control 
2. Long duration of DM 
3. Damage to blood vessels  
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4. Genetic susceptibility 
5. Autoimmune factors 
6. Lifestyle factors 
7. Smoking 
8. Alcohol 
 Classification of Diabetic Neuropathy[8]: 
· Rapidly reversible 
   Hyperglycemic neuropathy 
· Generalised symmetric polyneuropathy 
A. Acute sensory neuropathy 
B. Chronic sensorimotor neuropathy 
(i) Small fibre neuropathy 
(ii) Large fibre neuropathy 
                    C.Autonomic  neuropathy  
· Focal and multifocal neuropathies 
                     A.Focal-limb neuropathy 
                     B.Cranial neuropathy 
                     C.Proximal motor neuropathy(amyotrophy) 
                     D.Truncal radiculoneuropathy 
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                     E.Coexisting chronic inflammatory demyelinating         
                         Neuropathy 
Autonomic  neuropathy is further classified as- 
  a.  Sudomotor 
  b .Gastrointestinal 
  c .Cardiovascular 
  d .Genitourinary 
“Diabetic autonomic neuropathy (DAN) is deleterious and now a 
days a usual  complication of  diabetes.  Inspite of   its  ability of   to cause 
sudden painless heart attacks and death in patients due to cardiac 
autonomic instability , it is presumably under rated and untreated ”[7] 
DAN and other peripheral neuropathies mostly occurs along with 
other complications of diabetes  but  rarely can be isolated, sometimes 
precedes  other complications[7]. Major clinical manifestations of DAN 
include increased heart rate in resting state, intolerance to exercise , 
diarrhea, unawareness to hypoglycemia, gustatory sweating , impaired 
temperature regulation, altered sweating,  and sexual dysfunctions[7,27]. 
Almost all organ systems are affected by DAN (e.g., gastrointestinal [GI], 
genitourinary, and cardiovascular)[7]. GI disturbances  are frequent 
complications among these .  
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Clinical manifestations of Diabetic Autonomic Neuropathy     
Cardiovascular –  
Resting tachycardia ,exercise intolerance,orthostatic   hypotension,silent 
myocardial ischemia,intraoperative cardiovascular lability. 
Gastrointestinal- 
Esophageal dysmotility,gastroparesis,diarrhea,constipation,gall bladder 
stasis 
Genitourinary- 
Neurogenic bladder ,erectile dysfunction,retrograde ejaculation 
Sudomotor – 
Anhidrosis,hypohidrosis,gustatory sweating 
Hypoglycaemia counter regulatory- 
Hypoglycaemia unawareness,hypoglycaemia associated autonomic 
failure 
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CARDIOVASCULAR AUTONOMIC NEUROPATHY 
CAN is an impairment of autonomic control of the cardiovascular 
system in the setting of diabetes mellitus after exclusion of other 
causes.CAN is usually detected at a subclinical stage by means of several 
cardiovascular autonomic reflex tests[9]. 
Hyperinsulinemia due to insulin resistance can modulate 
autonomic activities ,inducing hemodynamic changes.Insulin may 
increase heart rate slightly,as shown in hyperinsulinemic  euglycemic 
clamps in healthy individuals[10,11] .Heart rate elevation occurs as a 
result of both vagal depression and cardiac sympathetic activation[10,11]. 
DM patients having CAN carries an increased risk for developing 
coronary artery disease and is also associated with poor prognosis once 
they  develop CAD.There  is  no “circardian variation” (morning increase 
in MI) of acute CVD events in diabetic patients with CAN. “Diabetic 
patients with CAN  are prone for sudden painless death due to ischemic 
myocardial infraction, rhythm disturbances, heart failure and rapid 
progression of diabetic nephropathy which cause further more damage to 
the myocardium by elevated BUN and other parameters”[12]. 
  Parasympathetic fibres are affected at relatively early stages. This 
leads to a relative increase in sympathetic tone,which causes attenuation 
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of expected increase in BP and heart rate changes during 
exercise.Decrease in parasympathetic tone causes exaggerated coronary 
vasoconstriction,leading to worsening of ischemia. 
PATHOGENESIS OF DIABETIC AUTONOMIC NEUROPATHY 
In presence of persistent hyperglycemia, polyol pathway is activated. 
Excess intracellular glucose is converted to sorbitol by enzyme aldose 
reductase. Increase in osmolarity which results due to  intracellular 
sorbitol and fructose accumulation causes Schwann cell damage, leading 
to deleterious effects on nerve conduction velocities. 
There is increased free radical formation leading to oxidative 
stress,causing endothelial cell dysfunction and neurotoxic effects. 
Microvascular theory is that chronic hypoxia occurring due to decreased  
endoneural  blood flow explains the pathogenesis of structural lesions of 
nerves.The normal “Vascular autoregulation” is said to be lost in 
chronic hyperglycemia.There is absolute and relative ischemia in the 
nerves and also decrease in Na+/K+ ATPase activity .This reduces nerve 
conduction velocity by decreasing axonal transport. 
Neurotrophic factors  like Nerve Growth Factor(NGF),Neurotrophin-
3,4/5,Insulin Like Growth Factor(IGF)-1 which are necessary for survival 
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of neurons are deficient in hyperglycaemic individuals.These also causes 
damage to nerve cells leading to neuropathy. 
PATHOGENIC MECHANISMS IN DAN 
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CARDIOVASCULAR DISORDERS ASSOCIATED WITH CAN 
There is an increase in cardiovascular events associated with subclinical 
CAN and due to sympathetic predominance. 
 
Silent myocardial ischemia(SMI) 
SMI may be detected by stress ECG ,Echocardiogram or by stress 
myocardial scintigraphy. Earlier meta analysis studies have shown higher 
rate of silent and painless heart attacks in patients with cardiac 
dysautonomia compared to normal individuals or diabetics without 
cardiac dysautonomia.  
Hypertension  
A defect in vagal activity and a relative sympathetic override 
contributes to hypertension. In  patients with T1DM or T2DM ,the 
prevalence of hypertension increases with CAN severity, which supports 
the role of CAN contributing to hypertension in diabetics[14]. 
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Left ventricular dysfunction 
CAN has been associated with left ventricular dysfunction, 
particularly diastolic dysfunction. 
QT interval prolongation 
QT   interval prolongation occurs due to loss of balance between 
sympathetic and parasympathetic innervations in heart, hypertrophy of 
left ventricle, changes in myocardium caused by electrolye and metabolic 
abnormalities and diseases affecting coronary arteries .Hyperglycemia 
and acute hypoglycemia can induce reversible QTc prolongation in 
healthy and diabetic patients. These all favours the basis for arrhythmias 
causing “Dead in Bed” syndrome. 
Abnormal circadian BP pattern 
Non dipping and reverse dipping[15,16] of BP may occur due to 
CAN.Several studies linked non -dipping to changes in day and night 
variation of sympathetics and parasympathetic system which consists of 
decreased rise in vagal activity and a dominance of sympathetic 
activity[15,16]. 
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Arterial stiffness 
Low-frequency peaking of systolic  BP variations in standing 
position using spectral analysis,correlates significantly with pulse 
pressure measured supine position,suggesting an increase in arterial 
stiffness associated with higher sympathetic activity[47]. 
Exercise intolerance 
There is a marked decrease in the ability to do strenous activities, 
in patients with cardiac dysautonomia ,which is  also accompanied by 
decrease in heart rate and variation in cardiac stroke volume with cardiac 
output variations. The severity of CAN is inversely related to maximal 
heart rate increase during exercise.CAN testing is a useful tool in 
identifying patients with potentially  poor exercise  tolerance ,thus 
preventing adverse outcomes during stress exercise tests and exercise 
training programs. 
Resting tachycardia 
During  early  stages  of  CAN   abnormalities  in  HRV  is  present,  
where as fixed HR and resting tachycardia are characteristically late 
findings in diabetics with vagal impairment. Patients who have damage in 
the vagal system shows higher heart rates at resting states in earlier stages 
of autonomic neuropathy. In later stages, patients have combined vagal 
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and sympathetic involvement, causing return of heart rate towards normal 
but remains elevated.Fixed heart rate unresponsive to exercise,stress,,or 
sleep indicates complete cardiac denervation. 
Postural hypotension 
In normal patients, on standing, BP is usually maintained, may 
have a slight rise or fall, but the drop of systolic BP usually doesn’t 
exceed 10 mm  of Hg. Orthostatic hypotension (OH) is referred to as a 
fall in blood pressure [i.e. 30 mm Hg for systolic or 10 mm Hg for 
diastolic] in response to postural change after 2 minutes, from supine to 
standing[17].  Symptoms of postural hypotension are  giddiness, light 
headedness, blackouts, disturbances in vision, vomiting, syncope, 
following sudden position change. It can become distressing   but some 
patients do not  have any symptoms[19]. It is due to inactivation of a 
baro-receptor initiated centrally mediated sympathetic reflex. It reflects 
failure of vasoconstriction in both systemic and vascular beds . 
Magnitude of systolic fall of BP on standing has no tight correlation with 
symptoms of dizziness. Orthostatic hypotension (OH) is often worse on 
getting out of bed during morning. Administration of insulin (acts as 
vasodilator),diuretics ,antihypertensives, and tricyclic antidepressants can 
aggravate OH. 
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Possible mechanisms of increased morbidity and mortality in 
diabetic cardiac autonomic neuropathy 
1) Silent MI ,impaired angina recognition and infarction 
2) Decreased ischemia threshold 
a) Impairment in coronary vasomotor regulation 
b) Increased resting heart rate 
c) Blunted chronotropic response to exercise 
3) QTc interval prolongation 
a) Increase in lethal arrhythmias 
b) Sudden death with or without MI 
4) Abnormal diastolic or systolic function 
a) Contributes to diabetic cardiomyopathy 
b) Affects natural history of congestive heart failure 
5) Increased perioperative risk 
6) Alteration in normal circardian variation of sympathomimetic activity 
Sudomotor and peripheral microvascular manifestations of DAN 
Sudomotor involvement is common in DAN.It is usually 
manifested as loss of sweating and dry skin in extremities accompanied 
by excessive sweating in trunk. Excessive sweating in trunk may occur as 
a compensatory phenomenon, as the proximal regions like head and trunk 
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are spared in dying back neuropathy. Gustatory sweating is less common. 
Microvascular skin flow is regulated by ANS and the rhythmic  
contractions of small arteries and arterioles are disordered in DAN. This 
is manifested as changes in skin texture, nail loss,anhidrosis,callus 
formation, fissures and cracks.Peripheral edema and venous prominence 
occur, which are associated with poor wound healing. There is high 
peripheral blood flow and abnormal local reflex vascular control due to 
loss of sympathetic vascular innervation.This leads to increased 
osteoclastic activity,reduction in bone density,susceptibility to fractures 
and results in Charcot’s neuroarthropathy. 
Sudomotor tests 
· “QSART (Quantitative Sudomotor Reflex Test)” 
·  TST(Thermoregulatory Sweat Test) 
·  Sweat Imprint 
·  Sympathetic Skin Response 
“QSART measures the axon reflex mediated sudomotor response, thus 
evaluating post ganglionic sudomotor function using  a cholinergic 
agonist.It  uses  the  principle of   iontophoresis of  a  cholinergic  
agonist”  [54].  “TST  is  a  test  which  determines  distribution  of  sweat  by  
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colour change of an indicator powder on skin after exposure to infrared 
light”[54]. 
Genito-urinary autonomic  neuropathy 
Neurogenic bladder  
Erectile dysfunction  
Sexual  dysfunction in women 
Ultrasound is performed to detect residual volume.micturography, 
cystometry and urometric studies ar performed. 
DIAGNOSIS OF CAN 
Subclinical CAN is a frequent condition that can be  documented 
with (Cardiovascular autonomic reflex tests)CARTs, which is the  gold 
standard  for clinical diagnosis of CAN .These  are  safe, clinically 
relevant, non invasive,easy ,reproducible, and standardized tests. 
“Parasympathetic function testing”[55]: 
“Heart –rate response to Valsalva manoeuvre”[55]: “During the  
strain period of Valsalva manoeouvre, BP falls and heart rate rises after 
release, Bp rises, overshooting the resting value and the heart rate slows 
down’[55].Though these reflex changes are complex,” the heart rate 
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response can be abolished by atropine, but remains unaffected by 
propranolol, which suggests that it is mediated by the vagus nerve”[55]. 
Patients with autonomic damage have slow fall in the blood pressure 
during the strain phase and it slowly returns to normal after release, with 
no overshot rise in BP and no change in HR. 
“In healthy people the Valsalva  maneouvre  has a four phased 
response”[48]. 
• Phase I: “There is at transient rise in BP and a fall in heart rate  mainly 
due aorta compression and propulsion of blood into the 
peripheral circulation. These  hemodynamic changes mostly occurs due 
mechanical factors”[48]. 
• Phase II: “There is an early fall in BP  followed by normalization of 
blood pressure. The change in BP is associated with rise in heart rate. 
Impaired venous return results decreased  cardiac output, causing a  
increased peripheral resistance and rise in sympathetic activity”[48]. 
•PhaseIII:With  cessation  of  expiration,there  is  a  fall  in  BP  with  rise  in  
heart rate 
• Phase  IV[48]:  “There  is  an  overshoot  of  BP  value  from  the  resting  
rate.This occurs because due to  venous return and cardiac output is 
restored with residual vasoconstriction”[48].   
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The test is performed by the patient blowing into a mouthpiece 
connected to a modified sphygmomanometer and holds it at a pressure of 
40 mm Hg for 15 seconds during which a continuous ECG is recorded. 
this test is performed 3 times with one minute interval between 
each.Patients with proliferative retinopathy should not undergo Valsalva 
because of the risk of retinal haemorrhage”[55].”The result of Valsalva 
test  is  expressed  as  the  ratio  of  the  longest  R-R  interval[55]  after  the  
manoeuvre(overshoot bradycardia following release) to the shortest R-R 
interval during the manoeuvre(tachycardia during the phase of 
strain),measured using a ruler from the electrocardiogram tracing..The 
mean of the three valsalva ratios is taken as the final value “[55 
“ HR variation with breathing” [29] 
“Normally the heart rate varies continually  depending on an intact 
parasympathetic nerve supply”[29, 55]. “At slow HR, deep respiration 
and in  adolescent patients and children, it becomes more evident. There 
is  total  abolition  of   HRV  or  considerable  decrease  in  this  response,  in  
diabetic patients with cardiac dysautonomia. HRV can be assessed by 
different types of breathing. quiet breathing. Deep inspiration and 
expiration at 6 times a minute is usually used. The patient is asked to do 
the above for 60 seconds, 5 seconds taking deep inspiration and 5 seconds 
deep doing deep exhalation. sits quietly and breathes deeply  at  a rate of  
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six breaths a minute . An ECG is recorded all along the manoeuvere taken 
throughout the period of deep breathing, and beginning of inhalation and 
exhalation tracings are marked”. The values of longest and shortest 
between two R waves is measured during each respiratory cycle and is 
measured with the help of a scale and converted to heart rate per minute. 
The longest and shortest RR interval is measured and its mean is taken. 
This bedside method is objective, comparatively easier when compared to 
other methods .  “HRV can also be expressed as the ratio of   the HR  at  
expiration to heart rate at inspiration, the so-called E:I ratio”[29,55]. 
“Heart-rate response to standing”[18] : 
During change from lying to standing position, there is an  
immediate rapid increase in heart rate which occurs  maximally 
at about the 15th beat following standing position. At about 30th    beat 
there is a relative overshoot bradycardia18. This is a vagus nerve mediated 
response. In diabetic patients with CAN, heart rate either shows minimal 
response or no response at all to standing position .Continuous ECG 
recordings are taken with patient lying comforatably in supine position. 
The patient is then asked to stand up without help and the point at which 
he begins to stand is noted in ECG. 
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Using a ruler, the shortest distance between two R waves  at about 15 th 
beat and the longest R-R interval at about 30 th beat post standing is 
noted[18]. “ The typical HR response to postural change is represented as 
30:15 ratio. With little patient cooperation, this test is simple and 
reproducible and donot depend other confounding factors”[18].  
Sympathetic Autonomic Function Test: 
 “BP response to standing position”[21]: 
“Usually during standing there is stagnation of blood in lower 
limbs which causes drop in BP, which is normally rectified by peripheral 
vasoconstriction”[21]. In diabetic patients with dysautonomia the drop in 
BP  persists  and  continues  to  be  at  a  lower  level  than  that  of  lying  
position.  
 “This test is performed by recording patient’s blood pressure using 
a sphygmomanometer, with the patient lying comfortably and then two 
minutes after standing position .. The difference between the systolic BP 
in supine position and the systolic BP in  standing  position is calculated 
as the postural drop in BP”[21].   
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Blood pressure variation to sustained handgrip[21]: 
Isometric exercises mostly are associated with increase in BP. 
Hand grip is one among the isometric exercises, which cause elevation of 
BP due to  HR dependent increase in cardiac output with unaltered 
peripheral vascular resistance[21]. 
.In patients with CAN, the normal reflex pathways are damaged 
and  this is associated with extensive sympathetic abnormalities. As a 
result, there is significant reduction in rise of BP during hand grip. Using 
hand grip dynamometer, initial maximum voluntary contraction is 
estimated. Hand grip is sustained at 30% of initial maximum contraction 
for long as possible  upto 5minutes. BP is recorded 3 times before and 
after hand grip. The mean of three diastolic BPs before hand grip is 
calculated. Result is expressed as a difference between highest DBP 
recorded during sustained hand grip and the mean diastolic BP before the 
hand grip 
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Summary of  cardiovascular autonomic tests 
Test Posture 
Appropriate 
test time 
Apparatus required 
Heart rate 
response to 
valsalva 
Sitting 5 min Sphygmomanometer,ECG 
Heart rate 
variation to 
deep breathing 
Sitting 2 min ECG 
BP to 
sustained hand 
grip 
Sitting 5 min Sphygmomanometer 
Heart rate 
response  
standing 
Lying to 
standing 
3 min ECG 
BP response to 
standing 
Lying to 
standing 
3 min sphygmomanometer 
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BATTERY OF AUTONOMIC TESTS-EWING AND CLARKE22 
Five simple, non invasive cardiovascular reflex tests based on works of 
Ewing et al [22] is used to assess autonomic function.  
 
Score Deep breathing 
Heart rate 
ratio 
during 
Valsalva 
Heart rate 
variability 
to standing 
BP 
variabilty 
to hand 
grip 
BP change 
to standing 
0 ≥15 ≥1.21 ≥1.04 ≥16 ≤10 
1 11- 14 1.11 -1.20 1.01 -1.03 11-15 11- 29 
2 ≤10 <1.20 ≤1 ≤10 ≥30 mm 
 
For grading of cardiovascular autonomic function, a battery of 5 tests 
using heart rate and BP responses are used. 
A score of 0-2 was assigned to each of these tests. Total score out of 10 is 
calculated. 
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1.Postural fall in systolic blood pressure (BP)[20] 
Systolic BP was measured with the patient in supine position and 2 
minutes after standing. 
A fall of systolic BP more than 30 mm Hg considered abnormal -Score  2 
11-29mm Hg fall is BP is considered as borderline-Score 1 
Less  than  or  equal  to  10  mm  Hg  is  taken  as  normal  -Score  0  
2. Increase in diastolic pressure during hand grip[20] 
Hand grip is sustained at 30% of the maximum for 5 minutes. 
A rise in diastolic BP in the opposite upper limb  is measured. 
Rise in diastolic BP ≥16mmHg considered Normal-Score 0  
11-15mmHg  considered Borderline-Score1 
<10 mm Hg considered Abnormal -Score-2 
3. Heart rate response to Valsalva manoeuvre- 
The patient is made to exhale forcefully into manometer after 
closing the nostrils to raise the pressure to 40 mmHg for 15 seconds. 
Ratio of longest RR interval to the shortest RR interval is measured and is 
expressed as Valsalva ratio.  
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Value ≥1.21 is considered as Normal and score of 0 is given. Value 
1.11-1.20 is considered Borderline and score of 1 is given.Value ≤1.10 
considered as Abnormal and a score of 2 is given  
4.  Heart rate response to deep breathing  
Patient in lying down position,  breathes in and out 6 times per 
minute. The differences in maximum and minimum heart rate during each 
cycle of breathing is being accurately calculated for accurate results. 
 ≥15 beats per minute considered Normal Score 0 
 11-14 beats per minute considered Borderline Score 1 
 ≤10 beats per minute  considered Abnormal Score 2 
5.  Heart rate response to standing  
 The RR interval is measured at 15 th and 30 th beat after standing 
from supine position 
A  ratio  of  30th beat  :15  th  beat   is  being  precisely   measured  and  a  
 Value of ≥1.04 is considered as Normal and as Score 0 
Value of 1.01-1.03  is considered as  Borderline and as  Score 1 
Value of  ≤1.00 is  considered as Abnormal and as Score 2 
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CAN SCORING 
Total score out of 10 is calculated.  
1. An overall score of ‘0’ or ‘1’ is considered normal 
2. A score 2,3,4 are considered borderlines     
3.  A  score ≥5 is judged is  abnormal  autonomic function 
CARTs (cardiovascular autonomic reflex testing) are done after avoiding 
confounding factors. Patients are advised to avoid strenuous 
exercises in the  preceding 24hours of tests. Caffeine, alcoholic 
beverages, smoking, and alcohol are avoided at least 2 hours 
before testing. Testing are done at fasting or 
after  2  hours  after  a  light  meal.  In  patients  who  are  on   insulin  
therapy, tests are done  at least 2 hours after taking short-acting insulin , 
and not during time of  hypoglycemia or  hyperglycemia. 
These test results are to be cautiously   interpreted in patients 
having chronic respiratory illness, obstructive sleep apnea ,cardiac 
diseases, in particularly in heart failure. Medications like  diuretics, 
sympatholytics ,antipsychotics which interfere with the test result should 
be advised to withdraw before performing these tests or the patients who 
needed these drugs for  their survival should not be included in this study.  
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Power Spectral Analysis 
Heart rate variability can be determined by frequency domained 
spectral analysis of R-R intervals. A 7 minute ,short R-R interval or a 
twenty four hour ECG recording can be used30.  “HRV can be measured 
over various frequency distribution with very minimal cooperation of 
patient”[30].  “The high-frequency region( 0.15-0.4 Hz) of power spectral 
band is usually denotes vagal activity. The lower frequency range (0.04-
0.15 Hz) denotes both sympathetic and vagal activity”[31]. 
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Cardiac Radionuclide Imaging 
Cardiac sympathetic innervations could be quantified using 
imaging using radionucleotides. MIBG is used in these techniques. It is 
an unmetabolized  noradrenaline analogue. “cardiac dysautomia shows 
reduction in MIBG uptake in patient’s myocardium”[32]. 
 However these methods are highly expensive and not done in our 
day to day clinical practices. 
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MANAGEMENT OF AUTONOMIC DYSFUNCTION 
Cardiac autonomic reflex tests can detect CAN at early stages in 
asymptomatic patients. Also, later stages have poor prognostic 
implications..Early detection aids in early initiation of therapies to limit 
or halt the progression of CAN, thus reducing the morbidity and 
mortality. 
 Evidence from the DCCT [33] suggests that near normal levels of 
glycemic status is “the best method to delay the occurrence of cardiac 
dysautonomia”[33]. Autonomic neuropathy progression may be 
influenced by proper   treatment measures in early  weeks[34,55],  Tight 
glycemic control can delay in progression of neuropathy, whereas 
reversal of the condition      is less likely[34]. 
Autonomic  neuropathy and hypoglycaemia has an overlap and 
autonomic neuropathy can lead to hypoglycaemic unawareness. So there 
should be caution in exercising  very strict glycemic controls.patients 
should be educated about the chance of hypoglycaemic episodes[36,37]. 
Several mechanisms have been attributed to the pathogenesis of 
diabetic neuropathy. These includes polyol pathway,neurotrophic factors, 
advanced glycated end products,oxidative stress etc .Timely identification 
of neuropathy  in diabetics enables the use of as the use of prophylactic 
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treatments such as ACE inhibitors and aspirin along with other 
pharmacological and non pharmacological methods. 
Nonpharmacological measures 
· Cessation of smoking, tailored exercise programs 
These are shown to improve autonomic functions 
· Body stockings and gravity suits 
Useful in patients with orthostatic hypotension- aimed at 
improvement in peripheral vascular resistance 
· High sodium diet,,elevation of head end while sleeping-may give 
symptomatic relief 
· “Staged” posture changing 
· Standing on crossed legs. 
· Dorsiflexing  the feet or doing handgrip exercises before standing 
Pharmacological measures 
Strict glycemic control,good blood pressure control and lipid 
reduction can slow down the progression of CAN 
Some studies have shown the use of  antioxidant,alpha lipoic acid 
in slowing or reversing progression of neuropathies. 
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Angiotensin converting enzyme(ACE)  
inhibitors,especially,quinapril has been shown to cause improvement in 
parasympathetic activity after 3 months of treatment. 
Cardioselective beta blockers(Atenolol) or propranolol can block 
central or peripheral sympathetic stimuli.This helps in restoration of 
parasympathetic-sympathtic balance. 
Orthostatic hypotension may be treated with  fludrocortisone  (0.1-
0.4 mg per day).This acts by increasing plasma 
volume..Pindolol,fluoxetine and intranasal or oral desmopressin have also 
been tried. 
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 QTc  INTERVAL AND CARDIAC AUTONOMIC NEUROPATHY 
    QT interval  is   the time interval  measured  between the beginning of 
the Q wave and the end of the T wave in the ECG. The QT interval 
represents the total duration of the ventricular activity,that is the 
electrical depolarisation and repolarisation of ventricles[23].QT interval 
may vary in different parts of the ventricles. 
1. The QT decreases with tachycardia,that is, with a diminution 
of R-R interval. 
2. The QT lengthens with bradycardia 
For a meaningful evaluation, the QT interval cannot be viewed in 
absolute terms and must be corrected for the effect of associated heart 
rate.  
 QT interval measurement 
Measurement of QT interval may present some difficulty at times.This 
happens because,it may be difficult to determine the exact beginning and 
end of the interval 
1) “Measured in either lead I,II or V5 ,V6.the beginning of QRS complex 
is best appreciated in leads with an initial q wave”[50]. 
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2) “The end of the T wave may be obscured by a superimposed U wave. 
Larger U waves are taken into consideration for measurement”[50] 
3) The end of T WAVE is  determined by the maximum slope intercept 
method [50]. 
Maximum slope intercept method 
 
Corrected QT interval[49,23] 
QTc  interval is corrected for a theoretically heart rate of sixty beats /min 
Bazett’s formula: 
 QTC = QT / √ RR. 
The RR interval measured between two consecutive R waves is expressed 
in seconds. 
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· Bazett’s formula is the most commonly used as it is simplest 
among all. 
· It under-corrects at heart rates less than 60  
· It over corrects at heart rates more than 60 
·  provides an adequate correction for heart rates between  60 – 100 
bpm. 
 
Causes of a prolonged QTc (>440ms)[23] 
1. During sleep-longer during sleep 
2. Hypokalemia  
3. Acute myocarditis from any cause, particularly rheumatic carditis 
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4. Hypocalcemia-mainly due to prolongation of ST segment 
5. Hypothermia 
6. MI-are more likely to develop complex arrhythmias 
7. Post-cardiac arrest 
8. Raised intracranial pressure 
9. Certain drugs-quinidine,procainamide,tricyclic antidepressants 
10. Congenital long QT syndrome 
An association between cardiac autonomic neuropathy and QT 
interval prolongation was demonstrated in many studies and it may 
predispose to sudden death in diabetes[24,25].Increased QT dispersion 
was also suggested as a marker of diabetic autonomic neuropathy[26]. 
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METHODOLOGY 
Study Design:     
A   Cross sectional study was conducted  to evaluate the prevalence 
of cardiac autonomic neuropathy among  Type 2 Diabetes Mellitus 
patients and to find the use of QTc interval in predicting it. 
Sample size 
Sample size =  Z2*(p)(1-p)/c2 
  p=60% 
(prevalence of CAN in type 2 DM, according to previous studies,  
(Pappachan et al.)) 
c= absolute precision taken as 10% ,keeping 95% confidence 
interval  
sample size =  1.96*1.96*0.6*0.4/0.1*0.1=92 
(rounded to 100) 
 Study Population: 
        100 Type 2 diabetic patients, both male and female, who satisfy all 
inclusion and exclusion criteria, from the outpatient department and 
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inpatients of Medicine department of Government Kilpauk Medical 
College, Chennai, will be included in this study 
DATA COLLECTION METHODS 
CRITERIA 
Inclusion criteria  
ü Type 2 diabetes diagnosed according to WHO criteria, already on 
treatment 
ü Both male and female are included in the study group. 
Exclusion criteria : 
ü Systemic hypertension 
ü Coronary Artery disease 
ü Documented Valvular disease  
ü Cardiac failure 
ü Age above 60 yrs 
ü Electrolyte imbalance(hypocalcemia, hypokalemia) 
ü Patients  who  are  on  any  drugs  that  would  interfere  with  the  
autonomic functions. 
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STUDY PERIOD: 
6months of study from March 2016 to September 2016 
DATA COLLECTION:  
All the patients are evaluated by detailed history including duration 
of diabetes , symptoms of autonomic neuropathy and relevant basic blood 
investigations  
 Battery of five autonomic function tests done in all cases (as 
described by Ewing and Clarke et al). Autonomic neuropathy testing 
using simple bed side tests was done in op department and  medical ward 
with the use of 12 lead ECG monitor, Pulse oxymeter and BP apparatus 
.The same 100 patients were tested after obtaining proper informed 
consent, with 10 minutes interval after each manoeuvre. 
The following 5 tests for detecting Cardiac Autonomic Neuropathy 
will be : 
BLOOD PRESSURE FOR POSTURAL OR ORTHOSTATIC 
HYPOTENSION 
“Bloodpressure recording is done when the subject is made to lie 
down and again 2 minutes after standing up. The difference in systolic 
pressure from lying to standing is a measure of  orthostatic 
hypotension”[46]. 
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“CHANGE IN HEART RATE TO VALSALVA 
MANOEUVRE”[46]:  
This test can be performed using a modified b.p apparatus. Patient blows 
in to the rubber tubing to raise the pressure to 40 mm of Hg, a long strip 
ECG in lead II is taken. Ratio of longest to shortest R-R interval is 
measured and mean ratio is obtained 
“DEEP BREATHING ASSOCIATED CHANGES IN HEART 
RATE”[46]: 
ECG is recorded continuously while patient is taking breath at a regular 
rate of 6-12 breaths/min.A difference of in heart rate <15 beats/min 
between expiration and inspiration is taken as abnormal 
“BLOOD PRESSURECHANGES DURING SUSTAINED HAND 
GRIP”[46] 
“Subject is given a ball and is asked to press the ball in his or her left 
hand for about 5 minutes Failure to rise the diastolic blood pressure more 
than 15 mm of Hg is considered as  an abnormal finding  and graded 
accordingly. 
HEART RATE RESPONSE TO STANDING 
 R-R interval is measured at beats 15 and 30.  
A 30:15 ratio is calculated   
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EWING’S AUTONOMIC FUNCTION TESTS AND SCORING 
Score 
Deep 
breathing 
Heart 
rate 
response 
to 
Valsalva 
ratio 
Heart rate 
variability 
to 
standing 
BP 
variability 
to hand 
grip 
BP 
change 
during 
standing 
0 ≥15 ≥1.21 ≥1.04 ≥16 ≤10 
1 11- 14 1.11 -1.20 1.01 -1.03 11-15 10- 29 
2 ≤10 <1..20 ≤1 ≤10 ≥30 mm 
Each test is graded as 
· Score 0 – normal 
· Score 1- borderline 
· Score 2 – abnormal 
1. An overall score of ‘0’ or ‘1’ is considered normal 
2.  Score 2,3,4 are considered borderlines 
3.  Score ≥5 is judged is abnormal  autonomic function 
QTc INTERVAL:  QT interval is determined on a 12 lead ECG taken at 
rest and correction for cardiac cycle is made 
The QTc is determined by using Bazetts  formula :   
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    QTc  =  QT⁄√RR interval 
    QTc>440 ms is taken as abnormal 
Apart from these cardiac autonomic reflex testing,,symptoms 
suggestive of autononomic dysfunction like light headedness, vertigo, 
palpitations, sweating  abnormalities, diarrhea, constipation etc.were 
asked .,using detailed questionnaire. 
BENEFIT TO THE PATIENTS 
They will be explained that having high blood glucose levels for 
many years may damage nerves through out body and CAN interferes 
with body’s ability to adjust blood pressure and heart rate. So keeping 
blood sugars under control is important. Exercises with gradual prolonged 
warm up and cool down periods is encouraged .Avoid sudden changes in 
postures, isometric exercises and straining. Avoid large,high carbohydrate 
meals, as it may cause sudden fall in bp. 
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DATA ANALYSIS 
Prevalence of cardiac autonomic neuropathy in diabetes mellitus 
was calculated. 
Difference in mean QTc interval between patients with  CAN and 
without CAN is analysed 
Specificity and sensitivity of QT interval in diagnosing diabetic 
autonomic neuropathy ,is calculated using Ewing’s cardiac autonomic 
dysfunction scoring as gold standard 
The collected data were analysed with IBM.SPSS statistics 
software 23 Version. For analysis of frequency of data in descriptive 
statistics continuous variables were analysed using mean and standard 
deviation and categorical variables were analysed as percentage. 
For the Multivariate analysis Oneway ANOVA with Tukey's Post-
Hoc test was used. 
The Receiver Operator Characteristic (ROC) curve analysis was 
utilized  to  determine  the   Sensitivity  ,Specificity  ,PPV  and  NPV  on  
comparison of  QTc with CAN Score. 
chi-square test was used to find association among categorical 
variables.  In  all  both  the  above  statistical  tools  the  p  value  of  0.05  is  
considered as significant level.  
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FREQUENCY TABLES 
SEX DISTRIBUTION 
 
Among the study population of 100 diabetic patients included in the 
study,from KMCH,58 were males and 42 females.. 
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DURATION OF DIABETES 
Duration of 
DM(yrs) 
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
< 5 yrs 21 21.0 21.0 21.0 
5 - 10 yrs 53 53.0 53.0 74.0 
> 10 yrs 26 26.0 26.0 100.0 
Total 100 100.0 100.0   
 
 
Among 100 patients from the study group, 21people had duration of 
diabetes less than 5 yrs,53 had duration 5-10 yrs, 26 had duration more 
than 10 yrs  
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SYMPTOMS OF CARDIAC AUTONOMIC NEUROPATHY 
 
Among 100 patients,34 were symptomatic and rest 66 were asymptomatic 
 
 
 
 
 
  
Symptoms Frequency Percent Valid Percent 
Cumulative 
Percent 
   
No 
 
 
66 
 
66.0 
 
66.0 
 
66.0 
Yes 34 34.0 34.0 100.0 
Total 100 100.0 100.0   
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CARDIAC AUTONOMIC REFLEX TESTS 
 
Among 100 patients, for heart rate response to deep breathing testing,8 
had abnormal scores,60 had border line scores and 32 were normal 
 
 
 
Heart rate response to deep breathing 
 
Heart rate 
difference Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
 ≥15 32 32.0 32.0 32.0 
11 - 14 60 60.0 60.0 92.0 
≤10 8 8.0 8.0 100.0 
Total 100 100.0 100.0   
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HEART RATE RESPONSE 
   
Heart rate response to Valsalva tests showed,normal score for 39 
patients,borderline scores for 46 people,abnormal scores for 15 people 
 
 
 
 
Heart rate response to Valsalva 
 
Heart rate ratio Frequency Percent Valid Percent 
Cumulative 
Percent 
 ≥ 1.21 39 39.0 39.0 39.0 
1.11 - 1.20 46 46.0 46.0 85.0 
≤1.10 15 15.0 15.0 100.0 
Total 100 100.0 100.0   
52 
 
HEART RATE RESPONSE TO STANDING 
Heart rate response to standing 
Heart rate ratio Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
 ≥1.04 58 58.0 58.0 58.0 
1.01 - 1.03 27 27.0 27.0 85.0 
≤ 1.0 15 15.0 15.0 100.0 
Total 100 100.0 100.0   
 
Out of 100 study population,15 had abnormal heart rate response to 
standing,27 had borderline scores, and 58 were normal. 
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BP RESPONSE TO HAND GRIP 
 
BP 
Response 
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
 ≥ 16 41 41.0 41.0 41.0 
11 - 15 52 52.0 52.0 93.0 
≤10 7 7.0 7.0 100.0 
Total 100 100.0 100.0   
 
41 patients had normal BP response to had grip,52 were borderline and 7 
were abnormal. 
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BP RESPONSE TO STANDING 
 
BP 
Response/standing 
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
 ≤10 48 48.0 48.0 48.0 
11 - 29 47 47.0 47.0 95.0 
≥ 30 5 5.0 5.0 100.0 
Total 100 100.0 100.0   
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Summary of  CAN test results 
Overall, among 100 patients in the study group,   8 people had abnormal 
results(score 2) for heart rate variability to deep  breathing, 15   had  
abnormal results for heart rate response to valsalva,  15 showed  
abnormal results for   heart rate response to standing,    7 had abnormal 
results for BP response to hand grip,5  had abnormal BP response to 
standing respectively, 
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CAN SCORE- FREQUENCY DISTRIBUTION 
CAN Score Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
 Abnormal 25 25.0 25.0 25.0 
Borderline 43 43.0 43.0 68.0 
Normal 32 32.0 32.0 100.0 
Total 100 100.0 100.0   
 
Among 100 patients,25 had an abnormal CAN Score, 
43 had borderline and  
32 had normal CAN Scores 
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DISTRIBUTION OF CAN SCORE  AMONG STUDY GROUP 
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QTc INTERVAL AMONG THE STUDY GROUP 
 
Among our study group of 100 diabetics,48 people showed a 
prolongation in corrected QTc(more than 440 milliseconds) 
 
 
QTc(ms) Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
 ≤  440 52 52.0 52.0 52.0 
> 440 48 48.0 48.0 100.0 
Total 100 100.0 100.0   
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ONE WAY ANALYSIS 
DURATION OF DM AND AGE 
Duration 
of  DM N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean Minimum Maximum Lower 
Bound 
Upper 
Bound 
< 5 yrs 
 
21 38 3.130 .683 36.58 39.42 32 44 
5 - 10 yrs 
 
53 46 5.000 .687 44.98 47.74 35 56 
> 10 yrs 
 
26 55 2.591 .508 53.88 55.97 50 59 
Total 100 46.83 7.118 .712 45.42 48.24 32 59 
 
Among the study group of 100 people,21 had less than 5 yrs DM 
,and the mean age was 38yrs (min-32,max-44).53 people had 5-10 yrs of 
DM and the mean age of the group was 46yrs(min-35,max-56).26 people 
had more than 10 yrs DM,with  mean age 55 yrs(min-50,max-59) 
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CROSS TABS-CAN SCORE AND DURATION OF DM 
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Among the study group of 100,4.8% of <5yrs diabetics,18.9% of 5-10 yrs 
diabetics and 53.8% of >10yrs diabetics showed abnormal CAN.Chi 
square tests showed there is a significant relation between duration of 
DM and CAN scores. 
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QTc AND DURATION OF DIABETES 
 
 
One way analysis 
qtc(
ms) N Mean 
Std. 
Deviati
on 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minim
um 
Maxim
um Lower 
Bound 
Upper 
Bound 
< 5 
yrs 
21 428.29 11.217 2.448 423.18 433.39 408 452 
5 - 
10 
yrs 
53 438.75 16.391 2.251 434.24 443.27 400 483 
> 10 
yrs 
26 454.27 15.803 3.099 447.89 460.65 432 500 
Tota
l 
100 440.59 17.682 1.768 437.08 444.10 400 500 
 
ANOVA 
 
 
 
qtc(ms) Sum of Squares df 
Mean 
Square F Sig. 
 
Between 
Groups 
8222.978 2 4111.489 17.546 .000 
 
Within 
Groups 
22729.212 97 234.322     
 
Total 30952.190 99       
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Among patients with duration of diabetes <5 yrs,mean QTc interval 
was428.29,among 5-10 yrs group,mean QTc interval was 438.75,and 
>10 yrs group mean QTc was 454.27.There was prolongation of QTc 
interval as duration of Diabetes increases. 
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QTc and CAN SCORE 
 
 
QTc and Can score cross tabulation and comparison was done,which 
showed statistical significance. Pearson Chi –Square value was 
33.150,and likelihood ratio of 37.546 with p value of <0.05 
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QTc * CAN Crosstabulation 
 
 
 Qtc interval 
CAN 
Total Abnormal Normal 
Qtc > 440 45 3 48 
≤  440 23 29 52 
Total 68 32 100 
 
 
 
 
 
 
QTc   prolongation had 66.2% sensitivity and 90.6% specificity in 
diagnosing CAN  in Diabetes Mellitus patients,with a 93.8 %positive 
predictive value,55.8% negative predictive value and an accuracy of 74% 
 
 
 
 
Sensitivity % 66.2 
Specificity % 90.6 
PPV % 93.8 
NPV % 55.8 
Accuracy % 74.0 
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In patients with CAN score abnormality, there was an increase in QTc 
interval 
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ROC Curve is an excellent way to compare diagnostic tests in statistics. 
its draws on the power of statistical tests.the curve is drawn between 
sensitivity on X –axis and 1-specificity on Y axis. 
 
Area Accuracy 
0.9-1 Excellent 
0.8-0.9 Good 
0.7-0.8 Fair 
0.6-0.7 Poor 
0.5-0.6 Fail 
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From the above ROC curves,area under curve was calculated for 
QTc.was .It came as 0.754.Thus QTc is fair in diagnosing CAN score. 
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DISCUSSION 
 Various previous studies demonstrated that cardiac dysfunction is 
common in Type 2 DM patients, and shows an increase in prevalence  as 
the duration of diabetes mellitus increases42-45.. 
 Our study among 100 diabetics in kilpauk medical college showed 
significant cardiac autonomic dysfunction among diabetes patients.42 
females and 58 males were included in our study ,selected after 
considering exclusion and inclusion criteria. Among 100 patients 21 had 
duration of diabetes less than 5 yrs,53 patients  had duration 5-10 yrs, 26 
had duration more than 10 yrs . Among 100 patients,34 were 
symptomatic and rest 66 were asymptomatic. 
  Among 100 patients in the study groups,  8 people had abnormal 
results(score 2) for heart rate variability to deep  breathing, 15   had 
abnormal results for heart rate response to valsalva,  15 showed  
abnormal results for heart rate response to standing,    7 had abnormal 
results for BP response to hand grip,5  had abnormal BP response to 
standing respectively, 
  Among 100 patients,25 had an abnormal CAN Score,43 had 
borderline and 32 had normal CAN Scores..CAN  score of 0,1 was taken 
as normal,2 to 4 was considered as borderline and ≥ 5 was considered as 
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abnormal. 
  Among our study group of 100 diabetics,48 people showed a 
prolongation in corrected QTc(more than 440 milliseconds). 
  Among the study group of 100,4.8% of <5yrs diabetics,18.9% of 
5-10 yrs diabetics and 53.8% of >10yrs diabetics showed abnormal 
CAN.Chi square tests showed there is a significant relation between 
duration of DM and CAN scores. 
  Out of 100 patients, mean QTc interval in patients with ≤5yrs of 
diabetes was 428.29(min-408 and max-452),5-10 yrs was 438.75(min-
400 ,max-483)and >10 yrs was 454.27(min-432 ,max-500).there was a 
statistically significant relation between QTc and diabetes. 
  Post Hoc tests done for multiple comparisons between duration of 
DM and QTc as dependent variable also showed statistical significance 
with p value <0.05 
 Among 48  patients with prolonged QTc interval,21 had abnormal CAN 
score, 24 had borderline score.Only 4 patients with abnormal CAN score 
had normal QTc  
Mohan et al 42 study from India ,studied can in 336 patients,which 
showed an increase in prevalence of CAN and duration of diabetes. 
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Pappachan J M et46 al  studies evaluated the usefulness ofl  (QTc) in the 
Electrocardiogram to diagnose Cardiac autonomic neuropathy in patients 
with  diabetes.  Sensitivity  and  specificity  of  QTc 
prolongation in diagnosing  CAN were 77% and 62.5% in type 1 
diabetes mellitus and 76.5% and 75% in type 2  diabetes.. The study 
concluded that QTcinterval  can be used to diagnose CAN with 
reasonable sensitivity and specificity46.  
 In our study,QTc   prolongation had 66.2% sensitivity and 90.6% 
specificity in diagnosing CAN  in Diabetes Mellitus patients,with  a  93.8 
%positive predictive value,55.8% negative predictive value and an 
accuracy of 74%.  
Thus, prevalence of  CAN among diabetic patients in our hospital is 
fairly high comparable to previous similar study and   QTC interval 
prolongation can be used as a relatively easier diagnostic tool 
 
 
 
 
 
75 
 
CONCLUSION 
The conclusions from our study are 
1. Prevalence of CAN among type 2diabets patients in our hospital is 
fairly high, 58% 
2. There  is  a  relation  between  prevalence  of  CAN  and  duration  of  
diabetes..prevalence of cardiac autonomic neuropathy increases 
with duration of diabetes 
3. QT c interval prolongation increases with increasing duration of  
diabetes and  CAN 
4. QTc prolongation can be used as a diagnostic tool in evaluating 
cardiac autonomic neuropathy with fair specificity and sensitivity 
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                                      PROFORMA 
 
NAME:                                                                  AGE:                                       SEX: 
SMOKING/ALCOHOL STATUS: 
DURATION OF DIABETES: 
HISTORY SUGGESTIVE OF AUTONOMIC NEUROPATHY: 
 
BLOOD PRESSURE:                                                   PULSE RATE: 
EXAMINATION OF CARDIOVASCULAR SYSTEM: 
TEST FOR CARDIOVASCULAR AUTONOMIC FUNCTION: 
 TEST 1 TEST 2  TEST3 MEAN 
VALSALVA RATIO     
DEEP BREATHING TEST 
(HEART RATE 
VARIABILITY) 
    
SUPINE TO STANDING 
HEART RATE 
RESPONSE 
    
BP RESPONSE TO 
STANDING  
    
BP RESPONSE TO 
SUSTAINED HAND GRIP 
    
CAN SCORING: 
EXAMINATION OF R.S: 
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EXAMINATION OF GIT: 
 
EXAMINATION OF CNS: 
 
ECG FINDING WITH QTc INTERVAL 
 
INVESTIGATIONS: 
HEAMOGLOBIN: 
TOTAL COUNT :                                                                  DIFFRENTIAL COUNT: 
COMPLETE  RFT :    
    SERUM POTASSIUM:                                                            SERUM CALCIUM: 
ECHOCARDIOGRAM 
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ETHICS COMMITTEE APPROVAL 
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ᾆயஒᾺᾗத᾿ பᾊவΆ 
ஆᾼᾫ ெசᾼயᾺபᾌΆ தைலᾺᾗ:  
 
இடΆ:           ெபாᾐ மᾞᾷᾐவᾷᾐவ ᾐைர 
                             அரᾆ  கீ῁பாᾰகΆ மᾞᾷᾐவ க᾿ᾥாி மᾞᾷᾐவமைன 
                        ெசᾹைன 
 
பᾱᾁெபᾠபவாிᾹ  ெபய᾽ : 
பᾱᾁெபᾠபவாிᾹ  வயᾐ :                     பᾱᾁெபᾠபவாிᾹ  எᾶ : 
 
ேமேல ᾁறிᾺபி᾵ᾌ῀ள மᾞᾷᾐவ ஆᾼவிᾹ விவரᾱக῀ எனᾰᾁ 
விளᾰகᾺப᾵டᾐ.   நாᾹ இῂவாᾼவி᾿ தᾹனிᾲைசயாக பᾱேகιகிேறᾹ.   எᾸத 
காரணᾷதினாேலா எᾸத ச᾵டசிᾰகᾤᾰᾁΆ உ᾵படாம᾿ நாᾹ இῂவாᾼவி᾿ 
இᾞᾸᾐ விலகிᾰெகா῀ள᾿லாΆ எᾹᾠΆ அறிᾸᾐ ெகாᾶேடᾹ. 
இᾸத ஆᾼᾫ சΆபᾸதமாகேவா,   இைத சா᾽Ᾰᾐ ேமᾤΆ ஆᾼᾫ 
ேமιெகா῀ᾦΆேபாᾐΆ இᾸத ஆᾼவி᾿பᾱᾁ ெபᾠΆ மᾞᾷᾐவ᾽ எᾹᾔைடய 
மᾞᾷᾐவ அறிᾰைககைள பா᾽Ὰபதιᾁ எᾹ அᾔமதி ேதைவயி᾿ைல என 
அறிᾸᾐ ெகா῀கிேறᾹ.   இᾸத ஆᾼவிᾹ ᾚலΆ கிைடᾰᾁΆ தகவைலேயா, 
ᾙᾊைவேயா பயᾹபᾌᾷதிᾰெகா῀ள மᾠᾰக மா᾵ேடᾹ. 
இᾸத ஆᾼவி᾿ பᾱᾁ ெகா῀ள ஒᾺᾗᾰெகா῀கிேறᾹ.    இᾸத ஆᾼைவ 
ேமιெகா῀ᾦΆ மᾞᾷᾐவ அணிᾰᾁ உᾶைமᾜடᾹ இᾞᾺேபᾹ எᾹᾠΆ 
உᾠதியளிᾰகிேறᾹ. 
 
 
பᾱேகιபவாிᾹ   ைகெயாᾺபΆ                             ஆᾼவாளாிᾹ   ைகெயாᾺபΆ 
இடΆ : 
ேததி  
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PATIENT CONSENT FORM 
Study detail:     “STUDY ON PREVALENCE OF CARDIAC 
AUTONOMIC NEUROPATHY IN TYPE 2 DIABETES 
MELLITUS AND USE OF QTc INTERVAL IN ITS PREDICTION” 
 
Study centre  :             KILPAUK  MEDICAL COLLEGE, CHENNAI 
Patients Name  : 
Patients Age  : 
Identification Number        : 
  Patient may check (     ) these boxes 
I  confirm that I have understood the purpose of procedure for the above study. I have 
the opportunity to ask question and all my questions and doubts have been answered 
to my complete satisfaction. 
I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time without giving reason, without my legal rights being affected. 
I understand that sponsor of the clinical study, others working on the sponsor’s behalf, 
the ethical committee and the regulatory authorities will not need my permission to 
look at my health records, both in respect of current study and any further research 
that may be conducted in relation to it,  even if  I  withdraw from the study I  agree to 
this access. However, I understand that my identity will not be revealed in any 
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information released to third parties or published, unless as required under the law. I 
agree not to restrict the use of any data or results that arise from this study. 
I agree to take part in the above study and to comply with the instructions given 
during the study and faithfully cooperate with the study team and to immediately 
inform the study staff if I suffer from any deterioration in my health or well-being or 
any unexpected or unusual symptoms. 
I hereby consent to participate in this study. 
I hereby give permission to undergo complete clinical examination and diagnostic 
tests including hematological, biochemical, radiological tests. 
 
Signature/thumb impression:    
 
Patients Name and Address:                   place   date 
 
 
Signature of investigator :    
 
 
Study investigator’s Name :                               place   date     
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MASTER CHART 
A Name Age Sex Duration of DM( yrs) Symptoms 
Heart rate 
to deep 
breathing 
Heart rate to 
Valsalva 
Heart 
rate/standing 
Bp/hand 
grip Bp/standing 
CAN 
Score A 
1 govindhan 50 M 8 y 12 1.1 1 14 25 7 483 
2 kamala 45 F 7 n 16 1.11 1.05 17 25 2 430 
3 angammal 38 F 5 y 13 1.15 1.04 13 30 5 436 
4 krishnan 52 M 12 n 9 1.05 1 14 20 8 476 
5 seetha 54 F 11 y 13 1.05 0.93 14 25 7 460 
6 vimala 40 F 5 Y 15 1.15 1.05 14 20 3 436 
7 Velu 55 M 13 y 9 1.05 0.93 9 28 9 487 
8 chandran 52 M 10 n 14 1.15 1.04 14 10 3 449 
9 shanthi 43 F 5 n 11 1.1 1 14 15 7 430 
10 anbalagan 35 m 3 n 11 1.04 0.94 12 25 7 449 
11 chelladurai 53 m 12 y 14 1.1 1.05 15 26 4 449 
12 kannappan 50 m 18 y 9 1.05 0.94 8 30 10 500 
13 ramasamy 54 m 10 n 12 1.05 1.05 8 25 6 476 
14 sasikala 35 f 5 n 15 1.2 1.05 17 8 1 432 
15 parvathy 40 f 6 n 14 1.15 1.04 15 12 4 400 
16 muniyammal 50 f 8 y 14 1.2 1.05 14 20 5 430 
17 pandiyan 35 m 5 n 12 1.15 1.04 10 14 4 460 
18 arivoli 52 m 14 y 9 1.14 1 12 30 8 476 
19 nazeer 50 m 5 n 11 1.2 1.04 10 15 5 438 
20 thangamma 49 f 5 n 16 1.21 1.05 16 15 1 400 
21 mani 43 m 4 y 14 1.14 1.05 14 15 4 434 
22 siva 32 m 2 n 15 1.23 1.06 16 6 0 426 
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23 shakthivel 35 m 3 n 16 1.15 1.04 15 10 2 443 
24 amirtham 58 f 20 y 10 1.12 1 14 20 7 449 
25 sekar 53 m 8 n 16 1.22 1.04 16 14 1 442 
26 anjalai 45 f 9 y 14 1.15 1.02 14 15 5 448 
27 shanmugam 44 m 7 n 13 1.12 1.05 16 14 4 460 
28 manogaran 50 m 14 y 14 1.15 1.02 9 20 6 452 
29 srinivasan 40 m 3 n 18 1.21 1.05 17 6 0 416 
30 amsa 41 f 9 y 13 1.16 1.04 14 18 4 432 
31 sivagami 50 f 10 n 14 1.1 1.02 14 16 7 448 
32 santhi 34 f 4 y 16 1.21 1.04 15 8 1 420 
33 marimuthu 41 m 7 n 16 1.22 1.04 14 8 1 436 
34 amudham 40 f 6 n 12 1.22 1.05 16 5 1 436 
35 sasindar 39 m 4 n 15 1.22 1.06 15 6 1 432 
36 babu 55 m 18 y 14 1.18 0.94 12 30 7 468 
37 annamalai 57 m 12 n 12 1.11 1.04 16 18 4 446 
38 pandian 40 m 6 n 13 1.22 1.05 17 4 1 438 
39 gopal 49 m 7 n 15 1.15 1.04 14 16 3 420 
40 mariyappan 58 m 14 y 9 1.09 1.02 15 24 8 452 
41 velu 52 m 9 n 14 1.19 1.03 16 8 4 442 
42 jagan 40 m 2 n 17 1.24 1.07 17 4 0 424 
43 dhanapal 46 m 5 n 14 1.21 1.04 14 8 2 412 
44 revathy 37 f 4 n 15 1.2 1.05 16 10 1 438 
45 leelavathy 56 f 8 y 14 1.22 1.02 14 15 4 438 
46 prem 46 m 5 n 14 1.23 1.05 17 8 1 432 
47 ambiga 35 f 4 n 16 1.24 1.06 16 4 0 426 
48 pushpa 56 f 12 y 13 1.18 1.02 14 8 4 442 
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49 muthu 52 m 8 n 14 1.21 1.04 14 20 3 456 
50 kaniappan 52 m 12 y 13 1.18 1.02 12 15 3 448 
51 palani 38 m 4 n 16 1.2 1.04 16 4 1 438 
52 jeevamma 50 f 8 y 14 1.22 1.04 16 16 2 442 
53 rammaih 47 m 6 n 14 1.24 1.05 18 4 1 428 
54 ravi 40 m 5 n 16 1.23 1.04 16 6 0 438 
55 sheik 42 m 7 n 13 1.19 1.02 17 8 3 432 
56 rosy 45 f 6 y 12 1.1 1.01 14 16 6 446 
57 gowri 57 f 11 y 13 1.2 1.04 14 18 4 448 
58 mariamma 59 f 16 y 14 1.09 0.98 14 30 8 456 
59 kannan 50 m 8 n 14 1.2 1.03 16 8 3 456 
60 amal 35 m 2 n 17 1.23 1.06 17 4 0 424 
61 shantha 56 f 11 n 14 1.18 1.04 12 12 4 438 
62 manoranjan 45 m 7 n 14 1.2 1.03 14 8 4 450 
63 yuvarani 39 f 3 n 13 1.22 1.04 16 6 1 430 
64 siddiq 40 m 5 n 14 1.23 1.04 14 8 2 438 
65 surya 42 m 6 n 12 1.18 1.01 16 10 3 436 
66 sankar 37 m 3 n 14 1.24 1.06 18 2 1 428 
67 radha 55 f 12 y 12 1.16 1.02 14 20 5 448 
68 asiya 50 f 10 y 12 1.21 1.02 16 16 3 442 
69 suganthi 49 f 8 n 16 1.16 1.02 14 14 4 442 
70 sathish 40 m 4 n 14 1.23 1.05 16 6 1 452 
71 srinivasan 58 m 12 n 12 1.17 1.05 12 13 4 432 
72 shanmugam 56 m 11 n 14 1.21 1.01 14 8 3 438 
73 mahesh 39 m 4 n 16 1.2 1.06 17 6 1 424 
74 thilaka 51 f 5 y 12 1.21 1.04 14 9 2 442 
75 govindhan 56 m 16 y 9 1.1 1.01 11 10 8 459 
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76 kamala 45 f 6 n 16 1.25 1.04 16 12 1 424 
77 ayisha 54 f 10 y 13 1.19 1.02 16 8 3 438 
78 karthik 36 m 2 n 14 1.24 1.05 17 4 1 428 
79 yamuna 39 f 4 n 16 1.22 1.01 16 6 1 408 
80 krishnan 59 m 15 y 12 1.18 0.93 14 18 5 449 
81 jaya 52 f 12 n 12 1.19 1.04 16 14 3 444 
82 gopi 50 m 9 y 16 1.16 1.01 14 12 4 456 
83 anita 38 f 4 n 14 1.23 1.05 16 4 1 412 
84 padma 48 f 8 n 16 1.22 1.04 14 10 1 410 
85 daisy 45 f 6 n 16 1.21 1.01 16 14 2 436 
86 varadhan 55 m 11 y 14 1.18 1.01 14 10 4 448 
87 amal 48 m 8 n 16 1.19 1.02 11 9 3 439 
88 ganga 54 f 12 n 14 1.21 0.93 16 12 4 442 
89 devan 56 m 14 y 10 1.14 0.93 9 20 8 460 
90 arumugam 45 m 5 n 16 1.22 1.01 14 10 2 446 
91 sekar 40 m 5 n 16 1.19 1.05 17 6 1 442 
92 emrose 44 f 4 n 12 1.22 1.04 16 4 1 422 
93 jancy 48 f 5 n 14 1.24 1.05 16 8 1 400 
94 noorjahan 50 f 8 n 16 1.22 1.04 14 10 1 435 
95 balan 48 m 9 n 17 1.16 1.01 14 8 3 452 
96 selvam 52 m 8 n 14 1.08 0.93 13 22 7 468 
97 ramesh 43 m 4 n 17 1.18 1.06 16 6 1 420 
98 murugan 48 m 9 n 16 1.24 1.01 14 10 2 436 
99 rose 49 f 8 n 14 1.23 1.05 16 14 2 440 
100 savithri 53 f 12 y 14 1.16 1.04 13 14 4 444 
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